REGENERON PHARMACEUTICALS, INC. Litigation

Oct 16, 2026

On Appeal

Sep 18, 2026

Motion to Dismiss Granted

The court has granted the defendants' request to dismiss the lawsuit. Depending on the court's decision, the plaintiffs may be allowed to file an updated complaint or pursue an appeal.

Nov 17, 2025

Motion to Dismiss

After reviewing the complaint(s) filed by plaintiffs, defendants have filed a motion requesting that the court dismiss some or all of the plaintiffs' claims. In a motion to dismiss, defendants might challenge the validity of plaintiffs' claims or adequacy of plaintiffs' pleadings. Once a motion to dismiss is filed, the judge will make a decision on whether part or all of the case should be dismissed or the case can proceed as alleged.

Oct 30, 2025

Second Amended Complaint

A new complaint has been filed on behalf of certain investors in REGENERON PHARMACEUTICALS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Sep 8, 2025

First Amended Complaint

A new complaint has been filed on behalf of certain investors in REGENERON PHARMACEUTICALS, INC.. Amended complaints may contain additional facts, parties, allegations, a change in the class definition, etc.

Jul 10, 2025

Appointment of Lead Plaintiff

The court has appointed a lead plaintiff to represent the interests of investors in the lawsuit. The lead plaintiff works with the attorneys handling the case, helps oversee the litigation, and represents the interests of the proposed class.

Jan 7, 2025

First Filed Complaint

A securities fraud class action complaint has been filed on behalf of certain investors in REGENERON PHARMACEUTICALS, INC..